TipRanks

Charles Elliott Sigal Insider Profile

4 Followers
Charles Elliott Sigal, Director at Vir Biotechnology, holds 49.81K shares in Vir Biotechnology (Ticker: VIR), holds 3.45K shares in Alnylam Pharma (Ticker: ALNY), holds 0.00 shares in Surface Oncology (Ticker: SURF).
tipranks
Charles Elliott Sigal

Charles Elliott Sigal
Vir Biotechnology (VIR)
Director

Ranked #86,927 out of 109,193 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-42.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
58.12%
41.03%
0.85%
A breakdown of Charles Elliott Sigal's holdings

Insider Roles

Alnylam Pharma
(ALNY)
Director
Vir Biotechnology
(VIR)
Director
Adaptimmune Therapeutics
(ADAPY)
Director
Roles that Charles Elliott Sigal holds in companies

Most Profitable Insider Trade

Stock:
Adaptimmune Therapeutics
(ADAPY)
Rating:Informative Buy
Date:May 18, 2016 - May 18, 2017
Return:-41.90%
The most profitable trade made by Charles Elliott Sigal

Charles Elliott Sigal's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Vir Biotechnology
May 28, 2026
Director
Uninformative Buy
―
$562.31K
Alnylam Pharma
May 22, 2026
Director
Uninformative Buy
―
$796.65K
Adaptimmune Therapeutics
May 19, 2016
Director
Informative Buy
23.40K
$11.67K
SURF
Surface Oncology
Sep 08, 2023
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Charles Elliott Sigal's performance on stock

Charles Elliott Sigal insider profile FAQ

What is the percentage of profitable transactions made by Charles Elliott Sigal?
The percentage of profitable transactions made by Charles Elliott Sigal is 0%.
    What is the average return per transaction made by Charles Elliott Sigal?
    The average return per transaction made by Charles Elliott Sigal is -42.70%.
      What stocks does Charles Elliott Sigal hold?
      Charles Elliott Sigal holds: VIR, ALNY, ADAPY, SURF stocks.
        What was Charles Elliott Sigal’s latest transaction?
        Charles Elliott Sigal latest transaction was an Uninformative Buy of ―.
          What was Charles Elliott Sigal's most profitable transaction?
          Charles Elliott Sigal’s most profitable transaction was an Informative Buy of ADAPY stock on May 18, 2016. The return on the trade was -41.90%.
            What is Charles Elliott Sigal's role in Vir Biotechnology?
            Charles Elliott Sigal's role in Vir Biotechnology is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.